W
WAVEMAN · COMPANY
HIMS · Hims & Hers Health, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

HIMS

Hims & Hers Health, Inc.
HEALTHCARE SERVICES · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · CIK 0001773751
FORM 144 · 6☆ WATCH
INSIDER NET · 180D
-$11.6M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
324
13F, latest reported quarter
REVENUE GROWTH
+59.0%
XBRL, annual
NET MARGIN
5.5%
CONVERSIONS · 180D
53
codes C/M, not in net · $397.2K priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$11.6M over 180 days
-$7.3M over 90 days
below 72% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
324 funds added or opened last quarter
more than 90% of Healthcare Services
REVENUE
+59.0% year over year
more than 91% of Healthcare Services
MARGIN
5.5% net margin
more than 70% of Healthcare Services
BUYBACKS
$90.0M repurchased, FY to 2025-12-31
more than 61% of Healthcare Services
SHORT
3.7 days to cover · settled 2026-07-31
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$11.6M across 7 people in 180 days.
324 funds added or opened positions in the latest 13F quarter, of 511 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -33.3%
-33.3%12M
-65%-26%+12%+51%2025-092025-102025-122026-032026-052026-072026-09 2025-09-15 · Okupe Oluyemi sold $6.5M2025-09-29 · Okupe Oluyemi sold $5.1M2025-09-17 · Dudum Andrew sold $3.3M2025-10-16 · Dudum Andrew sold $2.5M2025-10-16 · Dudum Andrew sold $2.5M2025-10-16 · Dudum Andrew sold $2.5M2026-03-17 · Chi Michael sold $2.4M2026-06-18 · Okupe Oluyemi sold $1.9M2025-09-16 · Dudum Andrew sold $1.7M2025-09-15 · Okupe Oluyemi sold $1.5M2025-09-16 · Dudum Andrew sold $1.5M2025-09-22 · Okupe Oluyemi sold $1.4M2025-09-16 · Dudum Andrew sold $1.3M2026-05-26 · WELLS DAVID B bought $1.2M2025-10-16 · Dudum Andrew sold $1.1M2025-10-16 · Dudum Andrew sold $1.0M2025-09-16 · Dudum Andrew sold $1.0M2025-09-16 · Dudum Andrew sold $958.4K2026-04-16 · Okupe Oluyemi sold $956.3K2025-09-16 · Dudum Andrew sold $954.0K2026-06-17 · Elshenawy Mohamed sold $946.3K2025-09-16 · Dudum Andrew sold $914.5K2025-09-16 · Dudum Andrew sold $896.5K2025-11-17 · Okupe Oluyemi sold $853.5K2026-06-18 · Carroll Patrick Harrison sold $830.4K2025-12-22 · Okupe Oluyemi sold $824.8K2025-09-17 · Chi Michael sold $694.3K2026-08-19 · Boughton Soleil sold $691.8K2025-10-03 · Okupe Oluyemi sold $669.3K2025-10-16 · Dudum Andrew sold $664.7K2025-10-17 · Okupe Oluyemi sold $662.3K2026-06-22 · Okupe Oluyemi sold $619.2K2026-04-20 · Okupe Oluyemi sold $588.6K2025-10-16 · Dudum Andrew sold $534.5K2025-09-17 · Carroll Patrick Harrison sold $506.1K2025-12-17 · Chi Michael sold $504.8K2026-04-17 · Okupe Oluyemi sold $501.1K2026-08-18 · Autor Deborah M. sold $467.1K2026-06-17 · Chi Michael sold $441.9K2025-09-17 · Becklund Irene sold $424.7K2025-12-17 · Carroll Patrick Harrison sold $367.9K2025-12-17 · Becklund Irene sold $308.8K2026-09-02 · Boughton Soleil filed to sell $98.0K2026-08-19 · Boughton Soleil filed to sell $691.8K2026-08-18 · Autor Deborah M. filed to sell $467.1K2026-07-22 · Pendarvis Christiane filed to sell $113.3K2026-07-06 · Oluyemi Okupe filed to sell $1.1M2026-06-18 · Carroll Patrick Harrison filed to sell $830.4K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $11.6M sold by insiders over 180 days, 324 funds added last quarter, $3.3M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYWGSPRVATDOCAVAHGHADUSSERABDSXENSG
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Hims & Hers Health, Inc. insiders sold a net $11.6M of stock across 618 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Boughton Soleil
Chief Legal Officer
SELL
2026-09-02
3,458.0
$98.0K
Okupe Oluyemi
Chief Financial Officer
SELL
2026-08-19
4,938.0
$148.1K
Boughton Soleil
Chief Legal Officer
SELL
2026-08-19
25,111.0
$691.8K
Autor Deborah M.
Chief Policy Officer
SELL
2026-08-18
16,773.0
$467.1K
Okupe Oluyemi
Chief Financial Officer
SELL
2026-08-17
9,388.0
$261.8K
618 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 613 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
28,703,514.0 sh
$995.2M
VANGUARD PORTFOLIO MANAGEMENT LLC
10,559,314.0 sh
$366.1M
VANGUARD CAPITAL MANAGEMENT LLC
9,541,384.0 sh
$330.8M
STATE STREET CORP
8,145,699.0 sh
$282.4M
MORGAN STANLEY
7,152,498.0 sh
$248.0M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Boughton Soleil
FILED 2026-09-02
$98.0K
Boughton Soleil
FILED 2026-08-19
$691.8K
Autor Deborah M.
FILED 2026-08-18
$467.1K
Pendarvis Christiane
FILED 2026-07-22
$113.3K
Oluyemi Okupe
FILED 2026-07-06
$1.1M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
VanEck Social Sentiment ETF
$2.4M POSITION · AS OF 2026-03-31
2.8%
Kurv High Income ETF
$687.0K POSITION · AS OF 2026-02-28
1.8%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$1.3M POSITION · AS OF 2026-03-31
1.6%
Global X HealthTech ETF
$569.9K POSITION · AS OF 2026-02-28
1.6%
Amplify Online Retail ETF
$1.5M POSITION · AS OF 2026-03-31
1.3%
Invesco S&P Midcap 400 Pure Growth ETF
$3.4M POSITION · AS OF 2026-04-30
1.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Andrew Dudum
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$23.0M
$159.7M
$17.5M
+110%
+13%
2024
$24.6M
$110.3M
$7.2M
+57%
-2%
2023
$14.4M
$21.4M
$6.5M
-42%
-24%
2022
$10.8M
$10.7M
$5.0M
-58%
-53%
2021
$15.2M
$26.8M
$3.3M
-58%
-10%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$2.3B$1.5B$872.0M$526.9M
GROSS PROFIT$1.7B$1.2B$714.9M$408.7M
OPERATING INCOME$105.6M$61.9M$-29.5M$-68.7M
NET INCOME$128.4M$126.0M$-23.5M$-65.7M
EPS (DILUTED)0.510.53-0.11-0.32
OPERATING CASH FLOW$300.0M$251.1M$73.5M$-26.5M
CASH$228.6M$220.6M$96.7M$46.8M
BUYBACKS$90.0M$83.0M$2.0M$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →